XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share Based Compensation.  
Schedule of restricted stock award activity

Three months ended March 31,

2024

2023

Shares

Weighted Average Grant-Date Fair Value

Shares

Weighted Average Grant-Date Fair Value

Unvested shares, January 1,

238,179

$

20.30

175,619

$

21.42

Granted

36,114

19.10

29,064

21.50

Vested

(11,224)

22.57

(3,162)

25.30

Forfeited

(649)

23.10

(514)

27.16

Unvested shares, March 31,

262,420

$

20.00

201,007

$

21.35

Schedule of Stock Option Activity

The Company’s stock option activity during the three months ended March 31, 2024, and 2023 are summarized below (dollars in thousands, except per share data, unaudited):

Three months ended March 31,

2024

2023

    

Shares

    

Weighted Average
Exercise Price

Weighted Average Remaining Contractual Term (in years)

    

Aggregate
Intrinsic
Value (1)

    

Shares

    

Weighted Average
Exercise Price

Weighted Average Remaining Contractual Term (in years)

    

Aggregate
Intrinsic
Value (1)

Outstanding at January 1,

343,449

$

25.02

$

447

352,249

$

25.06

$

348

Forfeited/Expired

(11,000)

$

27.43

$

(2,200)

$

27.67

$

Outstanding at March 31,

332,449

$

24.94

3.96

$

264

350,049

$

25.04

4.99

$

33

Exercisable at March 31,

332,449

$

24.87

3.90

$

264

325,649

$

24.89

4.85

$

33

(1)The aggregate intrinsic value of stock option in the table above represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock exceeds the exercise price of the option) that would have been received by the option holders had all option holders exercised their options on March 31, 2024. This amount changes based on changes in the market value of the Company's stock.